Evidence map›Paper›PMID 41222669›Full record

ReviewHerz2026

[ESC/EACTS guidelines 2025 on the treatment of valvular heart disease : New standards in diagnostics and treatment].

Anna Juliane Buch, Mateo Marin-Cuartas, Michael A Borger, Holger Thiele, Janine Pöss

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Herz, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna Juliane BuchUniversitätsklinik für Kardiologie, Herzzentrum Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland. anna.buch@helios-gesundheit.de.
Mateo Marin-CuartasUniversitätsklinik für Herzchirurgie, Herzzentrum Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland.
Michael A BorgerUniversitätsklinik für Herzchirurgie, Herzzentrum Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland.
Holger ThieleUniversitätsklinik für Kardiologie, Herzzentrum Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland.
Janine PössUniversitätsklinik für Kardiologie, Herzzentrum Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The treatment of valvular heart disease plays an important role in cardiovascular medicine. The 2025 European Society of Cardiology (ESC)/European Association for Cardio-Thoracic Surgery (EACTS) guidelines for the management of valvular heart disease set new standards for diagnostics and treatment based on scientific evidence with the aim to avoid both undertreatment and overtreatment. Recommendations for interventional treatment of valvular diseases are given greater importance compared to the 2021 guidelines. At the same time, surgical expertise remains indispensable, especially in younger patients and those with complex anatomy. Particular emphasis is placed on precise diagnostics using multimodal imaging, the recommendation for treatment of patients in high-volume centers (Heart Valve Centers) and an optimal patient selection by the multidisciplinary heart team. The ESC/EACTS guidelines advocate individualized, multidisciplinary treatment decisions based on the best available evidence. In practice, this can only be achieved by more intensive cooperation between the individual institutions of outpatient and inpatient care as well as specialized centers.

Indexed as

CardiologyHeart Valve DiseasesPractice Guidelines as TopicEuropeEvidence-Based MedicineHumansAortic valve diseaseInterventional treatmentMitral valve diseaseRecommendationsTricuspid valve disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.